EN DE

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) Fair Value & Analysis

Healthcare · US · Market cap $223K

VV Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC logo Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC VENCF · US
Price$0.0009
Fair Value$0.0009
Upside+0.0%
Quality37/100
Watch Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Loss-making · -91.1% net margin
negative free cash flow
Trails peers (3/9)
Narrow moat 8/100
Evidence: Low Range $0.0009 – $0.0009 Share as image

Fair value as of: Aug 13, 2026

From 1 valuation models · updated 4 days ago

Fair value updated Aug 13, 2026, revised from $0.0010 to $0.0009 (−10.3%) since Jul 31, 2026. Share price −10.0% over the past month.

Below-average quality, currently priced close to our fair value.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 months)

$0.0010 $0.0009 Fair Value $0.0009 Apr 2026 Aug 2026

White line = price, green steps = our fair value per fiscal year. As of Aug 13, 2026.

How to read this chart

4‑month range $0.0009 – $0.0010 · the $0.0009 price screens below the $0.0009 fair value. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) currently trades at $0.0009, while our model-based Fair Value estimate is $0.0009, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Over the trailing twelve months, Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC generated revenue of $2.0M at a net margin of -91.1%. Revenue declined 56.7% year over year. Fundamentals as of Aug 13, 2026

The share trades about 10% below its 52-week high, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 0%, VENCF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) $0.0100 $0.0100 $0.0200 50
All 1 models by family
Asset-Based
NCAV (Graham) $0.0100 $0.0100 $0.0200 50

Notify me when VENCF reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $2.0M
Revenue growth (YoY) -56.7%
Net margin -91.1%
Return on equity -155%
Free cash flow −$1.3M FY2025
Operating margin -61.1%
More key figures
EPS (TTM) $-0.0100

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 37/100

Of which business quality 37 · Market factors (momentum, volatility) 46

Profitability 12
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 66
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 17
Distance to the 52-week high (market factor)
Net Issuance 44
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is a venture capital firm specializing in seed/startups and early venture. It prefers to invest in cannabis sectors. The firm prefers to invest in companies based in United States, North America and beyond. Vencanna Ventures Inc. is based in Calgary, Canada.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2025 · reported fiscal years

Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC reported revenue of $4.0M in FY2025 versus $0 in FY2022. Reported net income was −$3.9M in FY2025.

Growth Quality 0/100
Revenue growth is weak, negative or inconsistent.
Revenue
FY22 $0
FY23 $0
FY24 $0
FY25 $4.0M
Net income
FY22 −$499K
FY23 −$303K
FY24 −$248K
FY25 −$3.9M

Watch VENCF: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC Fair Value". https://www.fairvalue-calculator.com/stock/VENCF

Peer Group

Drug Manufacturers - Specialty & Generic · 625 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 37 · Bottom 25%
Fair Value upside +0% · Above median
Return on assets -25% · Bottom 25%
Net margin (TTM) -91% · Bottom 25%
Operating margin (TTM) -61% · Bottom 25%
Revenue growth -57% · Bottom 25%

Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/B 0.06× · Cheaper than 75% of peers
P/S (TTM) 0.11× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 34 · sector 7
FUTURE 0 · sector 20
PAST 0 · sector 24
HEALTH 0 · sector 96
DIVIDEND 0 · sector 32

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥53.76 ¥25.94 -52%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,944 ₹989.50 -49%
Divi's Laboratories Limited DIVISLAB ₹8,500 ₹1,932 -77%
Torrent Pharmaceuticals Limited TORNTPHARM ₹4,915 ₹1,163 -76%
PharmaEssentia Corporation 6446 1,440 TWD 233.93 TWD -84%
Cipla Limited CIPLA ₹1,463 ₹1,001 -32%
Zydus Lifesciences Limited ZYDUSLIFE ₹1,167 ₹703.32 -40%
Lupin Limited LUPIN ₹2,281 ₹2,477 +9%
Mankind Pharma Limited MANKIND ₹2,433 ₹983.11 -60%
Dr. Reddy's Laboratories Limited DRREDDY ₹1,200 ₹874.79 -27%

Compare Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of $0.0009 versus a price of $0.0009, about +0% (fairly valued).
What is the fair value of VENCF?
Our model-based fair value for Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is $0.0009 (as of Aug 13, 2026), built from audited fundamentals. The current price is $0.0009.
What is the quality score of VENCF?
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC (VENCF)?
Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC reported trailing-twelve-month revenue of about $2.0M (latest available figure, as of Aug 13, 2026).
What is the net profit margin of VENCF?
The net profit margin of Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC is about -91.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Vencanna Ventures Inc. is formerly known as The Cannavative Group LLC and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.